Description
EMERGENCY ALBUMIN 5% 500 ML DRUGS SYMPTOMATIC RELIEF AND SUPPORTIVE TREATMENT IN MANAGEMENT OF SHOCK, BURNS, HYPOPROTHROMBINEMIA, ADULT RESPIRATORY DISTRESS SYNDROME, CARDIOPULMONARY BYPASS,ACUTE LIVER FAILURE, ACUTE NEPHROSIS, SEQUESTRATION OF PROTEIN-RICH FLUIDS, ERYTHROCYTE RESUSPENSION, HYPOTENSION OR SHOCK DURING RENAL DIALYSIS, HYPERBILIRUBINEMIA AND ERYTHROBLASTOSIS FETALIS.
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-09-24+$3,998= $3,998
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-09-24 | +$3,998 | $3,998 | EMERGENCY ALBUMIN 5% 500 ML DRUGS SYMPTOMATIC RELIEF AND SUPPORTIVE TREATMENT IN MANAGEMENT OF SHOCK, BURNS, H… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI W1KSV9EFK9H3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26120F0167 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,106 | FY2020 |
| 36C25918F3943 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $8,747 | FY2018 |
| 36C25918F3932 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $12,511 | FY2018 |
| 36C25918F1994 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $5,310 | FY2018 |
| VA26117F2620 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $5,710 | FY2017 |
| VA25717J2334 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $105,642 | FY2017 |
Other recipients under 6505 from 662-SAN FRANCISCO (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA662C19075 | AMERIDOSE, LLC | 662-SAN FRANCISCO | $24,685 | FY2011 |
| V662PPVFY10AUG | MCKESSON CORPORATION | 662-SAN FRANCISCO | $1,098,465 | FY2010 |
| V662PPVFY10JUL | MCKESSON CORPORATION | 662-SAN FRANCISCO | $1,135,366 | FY2010 |
| V662PPVFY10JUN | MCKESSON CORPORATION | 662-SAN FRANCISCO | $1,140,564 | FY2010 |
| VA662C09157 | AMERIDOSE, LLC | 662-SAN FRANCISCO | $19,993 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA662A00404_3600_V797P5159B_3600 · retrieved 2026-09-26.